Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of coronavirus disease 2019 (COVID-19). Conventional meta-analyses cannot fully address the heterogeneity of different designs and outcomes of randomized controlled trials (RCTs) assessing the efficacy of HCQ in outpatients with mild COVID-19. We conducted a pooled analysis of individual participant data from RCTs that evaluated the effect of HCQ on hospitalization and viral load reduction in outpatients with confirmed COVID-19. We evaluated the overall treatment group effect by log-likelihood ratio test (-2LL) from a generalized linear mixed model to accommodate correlated longitudinal binary data. The analysis included data from 11 RCTs. The outcome of virological effect, assessed in 1560 participants (N = 795 HCQ, N = 765 control), did not differ significantly between the two treatment groups (-2LL = 7.66; p = 0.18) when adjusting for cohort, duration of symptoms, and comorbidities. The decline in polymerase chain reaction positive tests from day 1 to 7 was 42.0 and 41.6 percentage points in the HCQ and control groups, respectively. Among the 2037 participants evaluable for hospitalization (N = 1058 HCQ, N = 979 control), we found no significant differences in hospitalization rate between participants receiving HCQ and controls (odds ratio 0.995; 95% confidence interval 0.614-1.610; -2LL = 0.0; p = 0.98) when adjusting for cohort, duration of symptoms, and comorbidities. This individual participant data meta-analysis of 11 HCQ trials that evaluated severe acute respiratory syndrome-coronavirus 2 viral clearance and COVID-19 hospitalization did not show a clinical benefit of HCQ. Our meta-analysis provides evidence to support the interruption in the use of HCQ in mild COVID-19 outpatients to reduce progression to severe disease.

An increased expression of vascular endothelial growth factor (VEGF) is associated with demyelinated lesions in both multiple sclerosis (MS) and its model (EAE), implicating changes in vasculature as a potential component of CNS plaque formation. The purpose of this study was to investigate the vascular changes in acute and chronic EAE in C57BL/6 mice induced with myelin oligodendrocyte glycoprotein (MOG ((35-55))) peptide. We investigated the functional contribution of VEGF to acute and chronic EAE by treating immunized mice with SU5416 (Semaxinib), a potent and selective inhibitor of VEGF receptor 2 (VEGFR2). Animals received seven daily injections of SU5416 (50 mg/kg) or vehicle beginning on the day after disease onset (acute study) or on day 45 post-immunization (chronic study). Spinal cord sections were collected on the day of sacrifice. Modulation of angiogenic gene expression was determined using RNA isolated from 4 acute and 4 non-immunized controls. MOG peptide induction produced extensive demyelination, immune cell infiltration, tissue laminin deposits, and axonal loss in lesions. VEGF expression was extensively increased in the acute mice, which correlated positively with clinical score. In the acute study, SU5416 treatment produced a significant clinical improvement versus vehicle controls (p<0.001), with less demyelination (-37%) and cellular infiltration (-23%) in the spinal cord (p<0.05). Treated animals also had significantly fewer blood vessels per section than controls (56.1+/-6.1 v. 81.6+/-11.5, p<0.05), and significantly reduced laminin abnormalities (28.9% of lesion area v. 46.8%, p<0.05). There was no improvement in clinical score or tissue pathology, and no difference in vessel number or lesion laminin expression, when SU5416 was administered during the chronic disease (all p>0.05). In the acute study only, VEGF staining correlated with demyelination and the extent of cellular infiltration in both control (r=0.723, r=0.665) and treated (r=0.681, r=0.487) animals (all p<0.05). Laminin staining in lesion areas was strongly correlated with tissue pathology for all animals in both the acute and chronic study (all p<0.001). Vascular alterations in MOG peptide-induced EAE in the mouse are accompanied by increased lesion-specific levels of VEGF, extensive laminin deposits in the tissue and altered transcription of numerous angiogenic factors. In the microarray studies, acute mice showed a significant increase in several angiogenic RNA transcripts, six of which were verified by RT-PCR, alanyl aminopeptidase, caspase 8, Hif1a, MMP-19, plasminogen activator inhibitor, and thrombospondin1.

A couple of years ago, The Big Book of Logos made publishing history. David E. Carter chose 2,500 logos currently being used and produced a major resource book for logo designers. Designers from all over the world contributed work for the book, and the variety of styles and techniques covered the complete creative spectrum. The Big Book of Logos became one of the best-selling graphics books of all time. This book was followed by The New Big Book of Logos. Another 2,500 designs, printed beautifully, and priced with the reach of everyone. Another huge selling book. And now, for The Third Big Book of Logos. David Carter has collected 2,500 more logos from all over the world. Logo designers are always looking for sources of inspiration, wanting to see what's new and this book has it all.

An examination of steady-state DRL behavior showed that a reinforced response was more likely to occur after a reinforced than after an unreinforced response. This finding was interpreted in support of the hypothesis that the reinforcing stimulus in a DRL schedule may exhibit discriminative properties. Additional support for the hypothesis was found in the rapid extinction and reconditioning reported after DRL conditioning.

Three groups of two rats each were given 300, 900, or 1500 water reinforcements for responses separated by at least 6 sec (DRL 6 sec). When reinforcement was subsequently withheld, resistance to extinction was generally low for all Ss, although there was some indication that it increased with the number of previous reinforcements. When reinforcement was again programmed, very rapid reconditioning was found for all Ss. The data are discussed in terms of the discriminative function of the reinforcing stimulus.

Acquisition of a button-pressing response for three values of a DRL schedule was observed for 12 human Ss under instructions to win as many points, indicated by a flashing light, as possible. All Ss showed a rapid development of a temporal discrimination and a rapid transition from DRL 3 sec. to DRL 6 sec. to DRL 10 sec. Several characteristics of stable DRL behavior were observed to be similar to those found with animal Ss.

A circuit using a stepping switch coupled to a number of rotary selector switches is suggested as a general solution to the problem of programming sequential events automatically. A number of applications are discussed including the programming of visual and auditory stimuli and the recording of responses under several different conditions.

Two pigeons were trained to peck at different keys. each associated with a different tone Intensity. Although the test tones were of the same Intensity as those used during training, simultaneous presentation of a light With the tone altered the probability of correct key choice In the same manner as increasing the intensity of the tone.